Tower Research Capital »

Tff Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Tff Pharmaceuticals (TFFP) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Tff Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tff Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tff Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0k 502 6.04

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Home Depot (HD)

View all positions for Tower Research Capital

Top funds holding Tff Pharmaceuticals

Carlson Capital
DRW Holdings
Westside Investment Management
Vanguard Group
Geode Capital Management
Renaissance Technologies
BlackRock
UBS Group
University of Texas Investment Management Company
Tower Research Capital
Royal Bank of Canada
Newbridge Financial Services Group
Gen-Wealth Partners
Wells Fargo & Company
Hm Payson & Co

View all funds holding Tff Pharmaceuticals